8 hours agoStart testing the new vaccine against Coddy-19 in people
Periskopi(6 years ago)
(6 years ago)The first healthy volunteer has received a small “ ” vaccine potential against Avid-19 developed by researchers from London's Imperial College. The contestant, who has sought to remain anonymous, is reported to be in good health. He reportedly received the vaccine on June 19th, writes the media of [...]
The first healthy volunteer has received a small “ ” vaccine potential against Avid-19 developed by researchers from London's Imperial College.
The contestant, who has sought to remain anonymous, is reported to be in good health. He reportedly received the vaccine on June 19th, writes foreign media, broadcasts news.net.
A second strengthening dose will follow within four weeks.
Human trials for Oxford ChAdOx1 vaccine nCoV-19 (AZD1222) began in April, in which more than 1,000 participants were involved.
Professor Robin Schatock, from the Imperial Infectious Disease Department, which is leading the study, said his team's work is “an important step” towards finding a cure.
We now look forward to quick recruiting in testing so that we can assess both the safety of the vaccine and its ability to produce neutral antibodies”, Schattock said.
Fifteen healthy volunteers are expected to receive the first dose in the coming days as part of the initial phase of testing.
